These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 7943186)

  • 1. Latent Epstein-Barr virus infection in cottontop tamarins. A possible model for Epstein-Barr virus infection in humans.
    Niedobitek G; Agathanggelou A; Finerty S; Tierney R; Watkins P; Jones EL; Morgan A; Young LS; Rooney N
    Am J Pathol; 1994 Oct; 145(4):969-78. PubMed ID: 7943186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective immunization against Epstein-Barr virus-induced disease in cottontop tamarins using the virus envelope glycoprotein gp340 produced from a bovine papillomavirus expression vector.
    Finerty S; Tarlton J; Mackett M; Conway M; Arrand JR; Watkins PE; Morgan AJ
    J Gen Virol; 1992 Feb; 73 ( Pt 2)():449-53. PubMed ID: 1311367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study.
    Leong IT; Fernandes BJ; Mock D
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):184-93. PubMed ID: 11505266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the simian Epstein-Barr virus-encoded latent membrane protein-1 in malignant lymphomas of SIV-infected rhesus macaques.
    Blaschke S; Hannig H; Buske C; Kaup FJ; Hunsmann G; Bodemer W
    J Med Virol; 2001 Sep; 65(1):114-20. PubMed ID: 11505452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective efficacy of depsipeptide in a xenograft model of Epstein-Barr virus-positive lymphoproliferative disorder.
    Roychowdhury S; Baiocchi RA; Vourganti S; Bhatt D; Blaser BW; Freud AG; Chou J; Chen CS; Xiao JJ; Parthun M; Chan KK; Eisenbeis CF; Ferketich AK; Grever MR; Chen CS; Caligiuri MA
    J Natl Cancer Inst; 2004 Oct; 96(19):1447-57. PubMed ID: 15467034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct patterns of viral antigen expression in Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus coinfected body-cavity-based lymphoma cell lines: potential switches in latent gene expression due to coinfection.
    Callahan J; Pai S; Cotter M; Robertson ES
    Virology; 1999 Sep; 262(1):18-30. PubMed ID: 10489337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of Epstein-Barr (EB) virus-induced lymphoma in cottontop tamarins by vaccination with the EB virus envelope glycoprotein gp340 incorporated into immune-stimulating complexes.
    Morgan AJ; Finerty S; Lovgren K; Scullion FT; Morein B
    J Gen Virol; 1988 Aug; 69 ( Pt 8)():2093-6. PubMed ID: 2841417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus-latent gene expression and tumor cell phenotype in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma. Correlation of lymphoma phenotype with three distinct patterns of viral latency.
    Hamilton-Dutoit SJ; Rea D; Raphael M; Sandvej K; Delecluse HJ; Gisselbrecht C; Marelle L; van Krieken HJ; Pallesen G
    Am J Pathol; 1993 Oct; 143(4):1072-85. PubMed ID: 8214003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
    Niller HH; Wolf H; Minarovits J
    Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus (EBV) infection in infectious mononucleosis: virus latency, replication and phenotype of EBV-infected cells.
    Niedobitek G; Agathanggelou A; Herbst H; Whitehead L; Wright DH; Young LS
    J Pathol; 1997 Jun; 182(2):151-9. PubMed ID: 9274524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus infection and associated products (LMP, EBNA2, vIL-10) in nodal non-Hodgkin's lymphoma of human immunodeficiency virus-negative Japanese.
    Ohshima K; Suzumiya J; Tasiro K; Mukai Y; Tanaka T; Kato A; Kikuchi M
    Am J Hematol; 1996 May; 52(1):21-8. PubMed ID: 8638607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccination against herpesvirus, fiction or reality?
    Morein B; Merza M
    Scand J Infect Dis Suppl; 1991; 80():110-8. PubMed ID: 1666442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunisation of common marmosets with vaccinia virus expressing Epstein-Barr virus (EBV) gp340 and challenge with EBV.
    Mackett M; Cox C; Pepper SD; Lees JF; Naylor BA; Wedderburn N; Arrand JR
    J Med Virol; 1996 Nov; 50(3):263-71. PubMed ID: 8923292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequent expansion of Epstein-Barr virus (EBV) infected cells in germinal centres of tonsils from an area with a high incidence of EBV-associated lymphoma.
    Araujo I; Foss HD; Hummel M; Anagnostopoulos I; Barbosa HS; Bittencourt A; Stein H
    J Pathol; 1999 Feb; 187(3):326-30. PubMed ID: 10398087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of viral and human dUTPase in Epstein-Barr virus-associated diseases.
    Fleischmann J; Kremmer E; Greenspan JS; Grässer FA; Niedobitek G
    J Med Virol; 2002 Dec; 68(4):568-73. PubMed ID: 12376965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Replication-defective recombinant adenovirus expressing the Epstein-Barr virus (EBV) envelope glycoprotein gp340/220 induces protective immunity against EBV-induced lymphomas in the cottontop tamarin.
    Ragot T; Finerty S; Watkins PE; Perricaudet M; Morgan AJ
    J Gen Virol; 1993 Mar; 74 ( Pt 3)():501-7. PubMed ID: 8383183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid in situ hybridization for the diagnosis of latent Epstein-Barr virus infection.
    Barletta JM; Kingma DW; Ling Y; Charache P; Mann RB; Ambinder RF
    Mol Cell Probes; 1993 Apr; 7(2):105-9. PubMed ID: 8391639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hodgkin's disease and peripheral T-cell lymphoma: composite lymphoma with evidence of Epstein-Barr virus infection.
    Niedobitek G; Baumann I; Brabletz T; Lisner R; Winkelmann C; Helm G; Kirchner T
    J Pathol; 2000 Aug; 191(4):394-9. PubMed ID: 10918214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of lytic Epstein-Barr virus (EBV) infection by radiation and sodium butyrate in vitro and in vivo: a potential method for treating EBV-positive malignancies.
    Westphal EM; Blackstock W; Feng W; Israel B; Kenney SC
    Cancer Res; 2000 Oct; 60(20):5781-8. PubMed ID: 11059774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new animal model for primary and persistent Epstein-Barr virus infection: human EBV-infected rabbit characteristics determined using sequential imaging and pathological analysis.
    Takashima K; Ohashi M; Kitamura Y; Ando K; Nagashima K; Sugihara H; Okuno K; Sairenji T; Hayashi K
    J Med Virol; 2008 Mar; 80(3):455-66. PubMed ID: 18205213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.